Data from Successful Transfer of Umbilical Cord Blood CD34<sup>+</sup> Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia Patients
Harry Dolstra(Radboud University Nijmegen), Nicolaas M. Schaap, Jos Paardekooper(Radboud University Nijmegen), Anniek B. van der Waart(Radboud University Nijmegen), Peter E. Westerweel(Albert Schweitzer Ziekenhuis), Joop H. Jansen(Radboud University Nijmegen), F.A. Maas, Gerwin Huls(University Medical Center Groningen), Mieke W.H. Roeven(Radboud University Nijmegen), M.H.C.H. Leenders, Bert A. van der Reijden(Radboud University Nijmegen), Carel Trilsbeek(Radboud University Nijmegen), Aniek O. de Graaf(Radboud University Nijmegen), Jan J. Cornelissen(Erasmus MC), Jan Spanholtz(AIMM Therapeutics (Netherlands)), Marleen Tordoir(Radboud University Nijmegen), Nicole M. A. Blijlevens(Radboud University Nijmegen), Fenna Bohme(AIMM Therapeutics (Netherlands)), Gerard M.J. Bos(Maastricht University), Tjeerd J.F. Snijders(Medisch Spectrum Twente), Frank Preijers, Hans Pruijt(Jeroen Bosch Ziekenhuis), Arnold van der Meer(Radboud University Nijmegen), Jeannette Cany, Nina Kok(AIMM Therapeutics (Netherlands)), Basav N. Hangalapura(Radboud University Nijmegen)
Cited by 0
Related Papers
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
|New England Journal of Medicine|1996|1.1k
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2018|1k
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2021|714